Cognitive Behavioral Intervention for Type 1 Diabetes

This trial explores whether cognitive behavioral intervention can help adults with type 1 diabetes improve their lifestyle and better manage blood sugar levels. Researchers will divide participants into two groups: one will receive usual care with additional attention (Attention Control Enhanced Usual Care Arm), and the other will try a new approach to improve sleep patterns (TranS-C Intervention Arm). The study seeks adults who have had type 1 diabetes for at least a year and are experiencing sleep issues. Those dealing with this form of diabetes and sleep difficulties might find this trial suitable. As an unphased trial, it offers a unique opportunity to explore innovative therapies that could enhance quality of life.

The trial information does not specify whether you need to stop taking your current medications.

Research has shown that the Transdiagnostic Sleep and Circadian Intervention (TranS-C) is generally safe. Studies found that this treatment improved sleep without causing major side effects. Participants reported better sleep and reduced depression, indicating that the treatment is well-tolerated. The primary goal is to enhance sleep patterns, benefiting overall health. No clear evidence links this treatment to serious negative effects. This intervention is designed to be safe for individuals with sleep issues and type 1 diabetes.¹²³⁴⁵

Researchers are excited about the Cognitive Behavioral Intervention for Type 1 Diabetes trial because it explores innovative ways to manage the condition by addressing sleep and circadian rhythms. Unlike standard care, which often focuses on insulin management and diet, the TranS-C Intervention targets sleep quality and consistency, aiming for 7-9 hours of sleep per night with less than 60 minutes' variation in sleep and wake times. This approach is unique because it considers the role of sleep in diabetes management, which could lead to better overall health and potentially improved blood sugar control. By working with health coaches, participants might see benefits beyond traditional diabetes treatments.

Research has shown that the TranS-C program, which participants in this trial may receive, can improve sleep quality and reduce insomnia severity. One study found that individuals using this method experienced significant improvements in sleep and a decrease in insomnia symptoms. Better sleep is linked to improved overall well-being and may aid blood sugar control in people with type 1 diabetes. Although the direct effects on blood sugar remain unproven, focusing on sleep and body clock health appears promising for supporting lifestyle changes and managing diabetes. Meanwhile, participants in the Enhanced Usual Care (EUC) Arm will work with a health coach focused on enhanced usual care.²⁴⁶⁷⁸